Harm reduction and needle exchange programmes (multiple letters) [16]

Lancet

Volumn 351, Issue 9118, 1998, Pages 1819-1820

  Lifson, A R ^a   Bennett, S S ^a   Bluthenthal, R N ^a   Kral, A H ^a   Lorvick, J ^a   Erringer, E A ^a   Edlin, B R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; DIAMORPHINE;

DISEASE TRANSMISSION; DRUG ABUSE; DRUG OVERDOSE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MORTALITY; NEEDLE; PRIORITY JOURNAL; ADDICTION; CASE REPORT; FATALITY; MALE; NOTE; PREVENTIVE HEALTH SERVICE;

FATAL OUTCOME; HEROIN; HIV INFECTIONS; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE-RELATED DISORDERS;

EID: 0032513836     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)78789-4     Document Type: Letter

References (5)

1. SS Bennett Needle-exchange programmes in the USA Lancet 351 1998 839
2. JK Watters M Downing P Case J Lorvick YT Cheng B Fergusson AIDS prevention for intravenous drug users in the community: street-based education and risk behaviour Am J Comm Psych 18 1990 587 596
3. JK Watters MJ Estilo GL Clark J Lorvick Syringe and needle exchange as HIV/AIDS prevention for injection drug users JAMA 271 1994 115 120
4. H Hagan DC Des Jarlais SR Friedman D Purchase MJ Alter Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program Am J Publ Health 85 1995 1531 1537
5. KJ Oliver SR Friedman H Maynard L Magnuson DC Des Jarlais Impact of a needle exchange program on potentially infectious syringes in public places J Acquir Immune Defic Syndr 5 1992 534 535